These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Glucose and lipid metabolism during long-term treatment with cilazapril in hypertensive patients with or without impaired glucose metabolism. Shionoiri H; Sugimoto K; Minamisawa K; Ueda S; Ebina T; Matsukawa T; Gotoh E; Ishii M J Cardiovasc Pharmacol; 1990 Jun; 15(6):933-8. PubMed ID: 1694916 [TBL] [Abstract][Full Text] [Related]
4. [Effect of cilazapril therapy on diastolic filling and left ventricular hypertrophy in patients with arterial hypertension]. De Simone R; Irace L; Perna B; Caruso C; Guida M; Iacono A Minerva Cardioangiol; 1993 May; 41(5):205-9. PubMed ID: 8355860 [TBL] [Abstract][Full Text] [Related]
5. Effect of cilazapril therapy on glucose and lipid metabolism in patients with hypertension. Shionoiri H; Takasaki I; Naruse M; Nagamoti I; Himeno H; Ito T; Ohtomi S; Hata T; Shindo K; Mikami H Clin Ther; 1995; 17(6):1126-35. PubMed ID: 8750404 [TBL] [Abstract][Full Text] [Related]
6. [Cilazapril in the treatment of patients with arterial hypertension]. Talipova IZh; Zaslavskaia RM; Berkinbaev SF Klin Med (Mosk); 2002; 80(8):50-2. PubMed ID: 12360621 [TBL] [Abstract][Full Text] [Related]
7. Changes in left ventricular mass during treatment with minoxidil and cilazapril in hypertensive patients with left ventricular hypertrophy. Pogátsa-Murray G; Varga L; Varga A; Abrahám Gy; Nagy I; Forster T; Csanády M; Sonkodi S J Hum Hypertens; 1997 Mar; 11(3):149-56. PubMed ID: 9175566 [TBL] [Abstract][Full Text] [Related]
8. Effect of cilazapril on glucose tolerance and lipid profile in hypertensive patients with non-insulin-dependent diabetes mellitus. Gans RO; Stehouwer CD; Bilo HJ; Goggin T; Kraaij CJ; Donker AJ; van der Veen EA Neth J Med; 1993 Oct; 43(3-4):163-73. PubMed ID: 8302395 [TBL] [Abstract][Full Text] [Related]
9. Effects of cilazapril on cardiac structure and function in hypertension. Moisejev VS; Ivleva AY; Gurochkin AB; Kobalava ZD J Cardiovasc Pharmacol; 1994; 24 Suppl 3():S70-2. PubMed ID: 7700070 [TBL] [Abstract][Full Text] [Related]
10. [The regression of left ventricular hypertrophy and improvement in diastolic filling during antihypertensive therapy with cilazapril]. Sabatini D; Fazio S; Cittadini A; Biondi B; Lucariello A; Picano T; Saccà L Cardiologia; 1993 Jun; 38(6):377-81. PubMed ID: 8402747 [TBL] [Abstract][Full Text] [Related]
11. Studies on the effect of two angiotensin-converting enzyme inhibitors, captopril and cilazapril, on platelet and vascular prostaglandin metabolism in vivo. Wagner B; Eichler HG; Schneider B; Blöchl-Daum B; Brenner B; Gasic S; Lechner K; Kyrle PA Naunyn Schmiedebergs Arch Pharmacol; 1992 Oct; 346(4):453-6. PubMed ID: 1436129 [TBL] [Abstract][Full Text] [Related]
12. [The evaluation of cilazapril efficacy in patients with stable arterial hypertension (a randomized study)]. Belousov IuB; Akhadov ShV; Leonova MV; Volkov MG Ter Arkh; 1995; 67(9):53-6. PubMed ID: 7495044 [TBL] [Abstract][Full Text] [Related]
13. [The regression of the structural-functional changes in the hypertrophic left ventricle during the long-term correction of the arterial pressure with Inhibace (cilazapril)]. Gurochkin AB; Ivleva AIa; Kobavlava ZhD; Moiseev VS Ter Arkh; 1994; 66(9):46-9. PubMed ID: 7992212 [TBL] [Abstract][Full Text] [Related]
14. Effects of long-term cilazapril treatment on glucose and lipid metabolism in hypertensive patients with non-insulin-dependent diabetes mellitus. Uchida K; Kigoshi T; Ishii T; Kitazawa M; Nakano S; Morimoto S Clin Ther; 1995; 17(4):729-34. PubMed ID: 8565036 [TBL] [Abstract][Full Text] [Related]
15. [Changes in the left ventricular mass, wall tension and left atrial filling in long-term antihypertensive therapy. A comparative study with cilazapril and a thiazide diuretic]. Marmor A; Schneeweiss A Cardiology; 1993; 82 Suppl 2():32-42. PubMed ID: 8519028 [No Abstract] [Full Text] [Related]
16. The effects of monotherapy or combined therapy with an angiotensin converting enzyme inhibitor following initial treatment with calcium channel blockers on residual cardiovascular abnormalities. Tomiyama H; Kimura Y; Sakuma Y; Matuno K; Yoshida H; Doba N Clin Exp Hypertens; 2000 Jul; 22(5):493-506. PubMed ID: 10937840 [TBL] [Abstract][Full Text] [Related]
17. [The changes in serum TXB2 and 6-keto-PGF1 alpha in 62 cases with renal disease]. Zhang ZF; Zhao YT; Shi XY Zhonghua Nei Ke Za Zhi; 1989 Jan; 28(1):25-7, 62. PubMed ID: 2737033 [TBL] [Abstract][Full Text] [Related]
18. Normalization of insulin resistance in non-obese essential hypertension by cilazapril treatment. Suzuki M; Ikebuchi M; Yokota C; Shinozaki K; Harano Y Clin Exp Hypertens; 1995 Nov; 17(8):1257-68. PubMed ID: 8563700 [TBL] [Abstract][Full Text] [Related]
19. Prostanoid response in the kidney of hypertensive subjects as part of renal counteraction to gallopamil-induced blood pressure decrease. Székács B; Juhász I Acta Med Hung; 1988; 45(3-4):349-63. PubMed ID: 3074278 [TBL] [Abstract][Full Text] [Related]
20. The short-term effects of cilazapril on left ventricular diastolic function. Koylan N; Oncül A; Mercanoğlu F; Orak E; Erzengin F; Büyüköztürk K J Cardiovasc Pharmacol; 1994; 24 Suppl 3():S42-4. PubMed ID: 7700064 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]